Having trouble accessing articles? Reset your cache.

PDL BioPharma, Roche cancer, ophthalmic, inflammation news

PDL BioPharma said Roche's Genentech Inc. unit has paid the full sum of $73.8 million owed to PDL from 2Q10 sales of

Read the full 228 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE